ITCI
Intra-Cellular Therapies, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Input momentum (manajer yang sebanding):
keluasan pemegang +13.3% ·
aliran saham +7.6% ·
posisi baru bersih +11.8%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Norges Bank ✦ (pasif) | 3.58M | +11.4% | $472.22M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 2.24M | +1795.5% | $295.12M | 0.3% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (pasif) | 1.83M | +6.7% | $241.74M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (pasif) | 1.78M | -5.0% | $234.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 923.81K | +72.8% | $121.87M | 0.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 844.07K | +62.1% | $111.35M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 621.20K | +97.5% | $81.95M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | Marshall Wace ✦ | 440.67K | -59.2% | $58.13M | 0.1% | ▼ Trim | 4 | SEC ↗ ×3 |
| 9 | Adage Capital Partners ✦ | 298.39K | -56.0% | $39.36M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 266.33K | -50.4% | $35.13M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 11 | Two Sigma Investments ✦ | 193.89K | +35.8% | $25.58M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 190.37K | -81.6% | $25.11M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 13 | Soros Fund Management ✦ | 116.59K | Baru | $15.38M | 0.4% | New | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 115.42K | -80.4% | $15.23M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 15 | Arrowstreet Capital ✦ | 79.29K | Baru | $10.46M | 0.0% | New | 1 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 38.10K | Baru | $5.03M | 0.1% | New | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 18.51K | +68.2% | $2.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Soros Fund Management | $15.38M | 0.4% |
| Arrowstreet Capital | $10.46M | 0.0% |
| GAMCO Investors | $5.03M | 0.1% |
Telah keluar
| Point72 Asset Management | $21.03M | adalah 0.1% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 1 saham, $2,540 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.